A newsletter from Life Science Ventures (issue 1) – March 2013.
DEALS - LEADING THERAPEUTIC AREAS
Continuing on from previous issues we provide an update on the therapeutic areas driving most deal activity in the life science sector.
As was the case throughout 2011 and 2012,the leading therapeutic category for deal making (biopharma, devices and diagnostics) in the first two months of 2013 remains the oncology sector, with over 100 deals completed in the two months.
The prevalence of diagnostics deals within the oncology category here highlights the growing importance of a targeted therapy that can be better matched up with an individual patient.
As per 2012, the therapeutic categories of hospital, CNS (central nervous system) and infectives continue to generate good deal flow, if not quite to the same level as the oncology sector.
Excerpted from newsletter dated March 2013 - see: Life Science Ventures website for full newsletter (link no longer available)